Neural signaling that encodes certain memories as negative could impact anxiety and substance misuse disorders, according to a recent study.
Sky Dominguez, a second-year student in the Medical Scientist Training Program, is currently studying the biological mechanisms underlying a sex difference in Alzheimer’s disease, as approximately two-thirds of those with the disease are women.
In the newly formed Center for Arrhythmia Research, teams of interdisciplinary clinicians and scientists will work together to discover both the underlying molecular causes of arrhythmias and new standards of care for their treatment.
Investigators at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a novel wearable device and are creating a set of data algorithms specifically tailored to catch early signs and symptoms associated with COVID-19.
Samuel Stupp, PhD, was awarded the 2020 Nanoscience Prize from the International Society for Nanoscale Science, Computation and Engineering.
For the first time, advanced prostate cancer has been treated based on the genomic makeup of the cancer, delaying disease progression for patients with a treatment-resistant form of prostate cancer.
Northwestern Medicine experts discuss the phenomenon of “caution fatigue,” where people may find it difficult to stay on high-risk alert after weeks of social distancing and isolation to stop the spread of COVID-19.
Ben Smith, a second-year medical student, led a study that found opioid prescriptions declined significantly between 2013 and 2018 in the Northwestern Memorial Hospital Emergency Department.
A novel drug called luspatercept may reduce blood transfusion burden for patients with transfusion-dependent beta-thalassemia, an inherited blood disorder.
A newly developed high-resolution brain mapping technology exceeds the lifespans of current platforms and may enhance how brain function is measured and how efficiently neurological diseases are diagnosed and treated.